Lindenberg D, Pitule-Schödel H
Psychiatrische Abteilung, Kreiskrankenhaus Tauberbischofsheim.
Fortschr Med. 1990 Jan 20;108(2):49-50, 53-4.
In a placebo-controlled double blind clinical trial, 38 out-patients with anxiety associated with neurotic or psychosomatic disturbances were treated with D,L-Kavain (Neuronika) or Oxazepam. The anxiolytic effectiveness of the two preparations was judged by means of the Anxiety Status Inventory (ASI) and the Self-Rating Anxiety Scale (SAS) of Zung. The substances proved to be equivalent in the nature and potency of anxiolytic action. No adverse drug reactions occurred.
在一项安慰剂对照的双盲临床试验中，38名患有与神经症或心身障碍相关焦虑症的门诊患者接受了D,L-卡瓦因（Neuronika）或奥沙西泮治疗。通过焦虑状态量表（ASI）和zung的自评焦虑量表（SAS）来判断这两种制剂的抗焦虑效果。结果证明这两种物质在抗焦虑作用的性质和效力上是等效的。未发生药物不良反应。
